AtriCure Return on Investment 2010-2024 | ATRC
Current and historical return on investment (ROI) values for AtriCure (ATRC) over the last 10 years.
| AtriCure ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-12-31 | $-0.04B | $0.52B | -7.57% |
| 2024-09-30 | $-0.03B | $0.53B | -6.42% |
| 2024-06-30 | $-0.04B | $0.54B | -6.63% |
| 2024-03-31 | $-0.03B | $0.53B | -6.11% |
| 2023-12-31 | $-0.03B | $0.53B | -5.18% |
| 2023-09-30 | $-0.02B | $0.52B | -4.23% |
| 2023-06-30 | $-0.03B | $0.52B | -4.81% |
| 2023-03-31 | $-0.04B | $0.52B | -6.71% |
| 2022-12-31 | $-0.04B | $0.52B | -8.18% |
| 2022-09-30 | $-0.05B | $0.52B | -9.75% |
| 2022-06-30 | $0.06B | $0.53B | 10.70% |
| 2022-03-31 | $0.06B | $0.53B | 10.96% |
| 2021-12-31 | $0.06B | $0.55B | 11.01% |
| 2021-09-30 | $0.05B | $0.56B | 10.41% |
| 2021-06-30 | $-0.05B | $0.44B | -11.48% |
| 2021-03-31 | $-0.05B | $0.45B | -9.53% |
| 2020-12-31 | $-0.04B | $0.48B | -10.14% |
| 2020-09-30 | $-0.04B | $0.48B | -10.40% |
| 2020-06-30 | $-0.05B | $0.48B | -12.89% |
| 2020-03-31 | $-0.04B | $0.30B | -14.08% |
| 2019-12-31 | $-0.03B | $0.32B | -10.92% |
| 2019-09-30 | $-0.02B | $0.33B | -7.08% |
| 2019-06-30 | $-0.02B | $0.28B | -6.71% |
| 2019-03-31 | $-0.01B | $0.28B | -5.16% |
| 2018-12-31 | $-0.02B | $0.30B | -7.32% |
| 2018-09-30 | $-0.02B | $0.22B | -7.71% |
| 2018-06-30 | $-0.02B | $0.21B | -8.44% |
| 2018-03-31 | $-0.02B | $0.21B | -12.17% |
| 2017-12-31 | $-0.03B | $0.20B | -12.82% |
| 2017-09-30 | $-0.03B | $0.19B | -15.74% |
| 2017-06-30 | $-0.03B | $0.20B | -14.83% |
| 2017-03-31 | $-0.03B | $0.20B | -15.44% |
| 2016-12-31 | $-0.03B | $0.21B | -14.98% |
| 2016-09-30 | $-0.03B | $0.21B | -16.55% |
| 2016-06-30 | $-0.03B | $0.22B | -18.48% |
| 2016-03-31 | $-0.03B | $0.20B | -19.08% |
| 2015-12-31 | $-0.03B | $0.20B | -18.49% |
| 2015-09-30 | $-0.02B | $0.13B | -16.25% |
| 2015-06-30 | $-0.02B | $0.13B | -12.17% |
| 2015-03-31 | $-0.01B | $0.13B | -10.55% |
| 2014-12-31 | $-0.02B | $0.13B | -12.69% |
| 2014-09-30 | $-0.02B | $0.14B | -14.17% |
| 2014-06-30 | $-0.02B | $0.13B | -19.69% |
| 2014-03-31 | $-0.02B | $0.13B | -24.32% |
| 2013-12-31 | $-0.01B | $0.08B | -23.30% |
| 2013-09-30 | $-0.01B | $0.04B | -24.32% |
| 2013-06-30 | $-0.01B | $0.04B | -28.35% |
| 2013-03-31 | $-0.01B | $0.04B | -30.48% |
| 2012-12-31 | $-0.01B | $0.02B | -33.33% |
| 2012-09-30 | $-0.01B | $0.02B | -32.56% |
| 2012-06-30 | $-0.01B | $0.02B | -22.99% |
| 2012-03-31 | $-0.01B | $0.02B | -22.73% |
| 2011-12-31 | $-0.01B | $0.02B | -22.99% |
| 2011-09-30 | $0.00B | $0.02B | -14.46% |
| 2011-06-30 | $0.00B | $0.02B | -15.19% |
| 2011-03-31 | $0.00B | $0.02B | -10.96% |
| 2010-12-31 | $0.00B | $0.02B | -17.39% |
| 2010-09-30 | $-0.01B | $0.02B | -27.78% |
| 2010-06-30 | $-0.01B | $0.02B | -42.11% |
| 2010-03-31 | $-0.01B | $0.02B | -42.35% |
| 2009-12-31 | $-0.02B | $0.02B | -67.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.558B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |